Human BCMA / TNFRSF17 Protein, His Tag, premium grade
DMF

  • TAA Beads MBS-C004 is now available for cell research.
Customer Reviews
Cat. No. / Size
Price
Qty
BCA-H522y-100ug
$455.00
BCA-H522y-1mg (500ug X 2)
$2720.00
ETA of in-stock products:2 business days

Product Details

  • Synonym

    TNFRSF17, CD269, BCM, BCMA

  • Source

    Human BCMA, His Tag, premium grade (BCA-H522y) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Ala 54 (Accession # Q02223-1).

    Predicted N-terminus: Met 1

    It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage.

    Request for sequence
  • Molecular Characterization

    BCMA Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 7.8 kDa. The protein migrates as 12 kDa and 14-18 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 0.01 EU per μg by the LAL method / rFC method.

  • Sterility

    Negative

  • Mycoplasma

    Negative

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 24 months in lyophilized state;
    2. -70°C for 12 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    BCMA SDS-PAGE

    Human BCMA, His Tag, premium grade on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-HPLC

    BCMA SEC-HPLC

    The purity of Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) was greater than 80% as determined by SEC-HPLC.

  • Bioactivity-FACS

     BCMA FACS

    2e5 of BCMA-CAR-293 cells transfected with anti-BCMA-scFv were stained with 100 μL of 0.3 μg/mL of Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) and negative control protein respectively, washed and then followed by FITC anti-6xHis tag antibody and analyzed with FACS (Routinely tested).

    Protocol
  • Bioactivity-ELISA

     BCMA ELISA

    Immobilized Human BAFF, Fc Tag at 5 μg/mL (100 μL/well) can bind Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) with a linear range of 0.031-0.5 μg/mL (QC tested).

    Protocol
  •  BCMA ELISA

    Immobilized Human APRIL, Fc Tag at 5 μg/mL (100 μL/well) can bind Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) with a linear range of 6-25 ng/mL (Routinely tested).

    Protocol
  •  BCMA ELISA

    Immobilized Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-Human BCMA Antibody, Human IgG1 with a linear range of 0.2-3 ng/mL (Routinely tested).

    Protocol
  •  BCMA ELISA

    Immobilized Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) at 2 μg/mL (100 μL/well) can bind Anti-BCMA Neutralizing Antibody, Mouse IgG1 with a linear range of 0.2-3 ng/mL (Routinely tested).

    Protocol
  • Bioactivity-SPR

     BCMA SPR

    Anti-Human BCMA MAb (human IgG1) captured on CM5 chip via Anti-Human IgG Fc antibodies surface, can bind Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) with an affinity constant of 13.0 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

    Protocol
  •  BCMA SPR

    Anti-BCMA Neutralizing Antibody, Mouse IgG1 captured on CM5 chip via anti-mouse antibodies surface can bind Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) with an affinity constant of 0.234 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

    Protocol
  • Bioactivity-BLI

     BCMA BLI

    Loaded Anti-Human BCMA MAb (human IgG1) on Protein A Biosensor, can bind Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) with an affinity constant of 29.1 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol
  •  BCMA BLI

    Loaded Human APRIL, Fc Tag on Protein A Biosensor, can bind Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) with an affinity constant of 10.9 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol
  •  BCMA BLI

    Loaded Human BAFF, Fc Tag on Protein A Biosensor, can bind Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) with an affinity constant of 0.64 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol

Customer Reviews
Writing Reviews

Background

Tumor necrosis factor receptor superfamily member 17 (TNFRSF17) is also known as B-cell maturation protein (BCMA), CD antigen CD269, which is a member of the TNF-receptor superfamily. TNFRSF17 contains one TNFR-Cys repeat. TNFRSF17 is expressed in mature B-cells, but not in T-cells or monocytes. TNFRSF17 is receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. TNFRSF17 promotes B-cell survival and plays a role in the regulation of humoral immunity. TNFRSF17 can activate NF-kappa-B and JNK.

Recent Advances

 
Drug Development Progress
  • English Name:

    B-cell maturation protein

  • Category:

  • Approved Drugs:

    7 Details

  • Drugs in Clinical Trials:

    117 Details

  • Highest Development Stage:

    Phase 3 Clinical

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background